Annual Congress Vienna 2012

Saturday, 01.09.2012
Sunday, 02.09.2012
Monday, 03.09.2012
Tuesday, 04.09.2012
Wednesday, 05.09.2012

Citations should be made in the following way: Authors. Title. Eur Respir J 2012; 40: Suppl. 56, abstract number.



Pulmonary circulation: clinical treatment

Oral Presentation
Chairs: N. Galie (Bologna, Italy), G. Simonneau (Le Kremlin-Bicêtre, France)
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
M. Hoeper, R. Barst, N. Galie, P. Hassoun, N. Morrell, A. Peacock, G. Simonneau, V. Tapson, F. Torres, D. Lawrence, D. Quinn, H.A. Ghofrani (Hanover, Giessen, Germany; New York, Baltimore, Durham, Dallas, Cambridge, United States Of America; Bologna, Italy; Cambridge, Glasgow, Horsham, United Kingdom; Orsay, France)
Congress or journal article abstract
Congress or journal article abstract
Management of chronic thromboembolic pulmonary hypertension (CTEPH): A physician-based perception study
H. Tiede, B. Hinzmann, N. Bawden, I. Preston (Giessen, Berlin, Germany; London, United Kingdom; Boston, United States Of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
The anti-proliferative effects of apelin on pulmonary adventitial fibroblasts
L. Brash, C. Church, R. Wadsworth, A. Peacock, D. Welsh (Glasgow, United Kingdom)
Congress or journal article abstractSlide presentationMultimedia files
Congress or journal article abstractSlide presentationMultimedia files
Hemodynamics and response to therapy of pulmonary hypertension in patients with interstitial lung disease: Preliminary results of the "HYPID" prospective study
V. Cottin, M. Reynaud-Gaubert, J. Traclet, D. Montani, H. Nunes, B. Wallaert, B. Camara, C. Khouatra, D. Launay, S. Marchand-Adam, D. Israel-Biet, R. Magnier, L. Tétu, S. Zeghmar, L. Kiakouama, M. Humbert, J.F. Cordier (Lyon, Marseille, Clamart, Bobigny, Lille, Grenoble, Tours, Paris, Caen, Toulouse, France)
Congress or journal article abstract
Congress or journal article abstract
Cicletanine in pulmonary arterial hypertension (PAH): Results from a phase 2 randomized placebo-controlled trial
A. Waxman, R. Oudiz, S. Shapiro, M. Gomberg-Maitland, A. Keogh, D. Badesch, R. Frantz, C.G. Elliott, H. Gillies, G. Walker (Boston, Torrance, Los Angeles, , Denver, Rochester, Murray, Foster City, United States Of America; Sydney, Australia)
Congress or journal article abstractSlide presentationMultimedia files
Congress or journal article abstractSlide presentationMultimedia files
Pulmonary hypertension due to alveolar hypoventilation: Functional impact and improvement of haemodynamics and exercise capacity under non-invasive positive pressure ventilation
M. Held, J. Walthelm, S. Baron, C. Roth, B. Jany (Würzuburg, Germany)
Congress or journal article abstract
Congress or journal article abstract
Improved right ventricular function after substantial afterload reduction in patients with pulmonary arterial hypertension
M. van de Veerdonk, T. Marcus, H.J. Bogaard, N. Westerhof, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
Congress or journal article abstract
Congress or journal article abstract